OnKure Therapeutics

0 followers


OnKure is committed to the discovery and development of best-in-class precision medicines that target biologically validated drivers of cancer.

Industries

Headquarters

Stage

Employees

Links

Org chart

Anthony D. Piscopio
CEO & President

Anthony D. Piscopio

Collapse
Jim Winkler
Chief Scientific Officer
Jennifer Diamond
Chief Medical Officer
Duncan Walker
Chief Development Officer
Keith M. Olivia
General Counsel, SVP, Corporate Affairs & Secretary
James Blake
SVP, Computational Drug Discovery
Mark L. Boys
VP, Discovery Chemistry
Ann Howell
VP, Regulatory Affairs
Duncan W.
Chief Development Officer (cdo)